MedPath

Effect of inhaled Amikacin and Colistin in prevention of pneumonia

Not Applicable
Recruiting
Conditions
Ventilator-associated pneumonia (VAP).
Unspecified bacterial pneumonia
J15.9
Registration Number
IRCT20201015049030N3
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
126
Inclusion Criteria

Adult patients (18 or above)
Who has been under invasive mechanical ventilation for at least 48 hours

Exclusion Criteria

Patients who have been under mechanical ventilation for at least 120 hours.
They are suspected or confirmed to have VAP
Suffering from acute kidney injury, chronic kidney failure (glomerular filtration rate <30 ml per minute)
Having a tracheostomy tube
?Extubation within the next 24 hours
Patients with evidence of aminoglycoside resistance in their blood or tracheal culture antibiogram report.
History of any occurrence of myasthenia gravis.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath